Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil-Reference-Cited by-同舟云学术

Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil

Published:2018-06-25 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Omoto Shinya,Speranzini Valentina,Hashimoto Takashi,Noshi Takeshi,Yamaguchi Hiroto,Kawai Makoto,Kawaguchi Keiko,Uehara Takeki,Shishido Takao,Naito Akira,Cusack Stephen^ORCID

Funder

EMBL and Shionogi & Co., Ltd. Osaka, Japan.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-27890-4.pdf

Reference47 articles.

1. Thompson, W. W. et al. Estimates of US influenza-associated deaths made using four different methods. Influenza and other respiratory viruses 3, 37–49, https://doi.org/10.1111/j.1750-2659.2009.00073.x (2009).

2. Lambert, L. C. & Fauci, A. S. Influenza vaccines for the future. The New England journal of medicine 363, 2036–2044, https://doi.org/10.1056/NEJMra1002842 (2010).

3. Dong, G. et al. Adamantane-resistant influenza a viruses in the world (1902–2013): frequency and distribution of M2 gene mutations. PloS one 10, e0119115, https://doi.org/10.1371/journal.pone.0119115 (2015).

4. Treanor, J. J. et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. Jama 283, 1016–1024 (2000).

5. Nicholson, K. G. et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 355, 1845–1850 (2000).

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo;Antiviral Research;2024-10

2. Design and synthesis of 7-membered lactam fused hydroxypyridinones as potent metal binding pharmacophores (MBPs) for inhibiting influenza virus PAN endonuclease;European Journal of Medicinal Chemistry;2024-10

3. Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022–2023 influenza season in Japan;Antiviral Research;2024-09

4. High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro;Antiviral Research;2024-09

5. Baloxavir Resistance Markers in Influenza A and B Viruses in the Americas;Drug, Healthcare and Patient Safety;2024-09